drugset / Trial / NCT03776955
Beta-blockers for Oesophageal Varices
Phase 4
Unknown
1200 enrolled
King's College Hospital NHS Trust
Brighton and Sussex University Hospitals NHS Trust · collabCardiff University · collabGuy's and St Thomas' NHS Foundation Trust · collabKing's College London · collabSt George's University Hospitals NHS Foundation Trust · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To determine if carvedilol reduces the rate of variceal haemorrhage in patients with cirrhosis and small oesophageal varices
Timeline
- Start
- 2019-06-17
- Primary completion
- 2024-09
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 6.25 mg | Oral |
| Subject | Carvedilol | Other / unclassified | 12.5 mg | Oral |